These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 6965763)

  • 21. Platelet inhibitors in coronary-artery bypass operations.
    Gohlke H; Gohlke-Bärwolf C
    N Engl J Med; 1982 Dec; 307(23):1453-4. PubMed ID: 6752721
    [No Abstract]   [Full Text] [Related]  

  • 22. [Prevention of early graft occlusion after coronary bypass grafting by post-operative reduction of plasma fibrinogen by H.E.L.P. apheresis. First evaluation of 12 patients treated during our study (44 bypasses)].
    Blessing F; Jaeger BR; Oberhoffer M; Reichart B; Seidel D
    Z Kardiol; 2003; 92(Suppl 3):III42-7. PubMed ID: 14663601
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevention of closure of aorto-coronary venous bypass grafts.
    Dale J
    Scand J Haematol Suppl; 1981; 38():131-41. PubMed ID: 6977837
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Problems of the operated patient and suggestions for their treatment].
    De Vita C
    G Ital Cardiol; 1982; 12(3):227-30. PubMed ID: 6983468
    [No Abstract]   [Full Text] [Related]  

  • 25. Management of surgical patients receiving anticoagulation and antiplatelet agents.
    Thachil J; Gatt A; Martlew V
    Br J Surg; 2008 Dec; 95(12):1437-48. PubMed ID: 18991253
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Perioperative use of tirofiban hydrochloride (Aggrastat) does not increase surgical bleeding after emergency or urgent coronary artery bypass grafting.
    Bizzarri F; Scolletta S; Tucci E; Lucidi M; Davoli G; Toscano T; Neri E; Muzzi L; Frati G
    J Thorac Cardiovasc Surg; 2001 Dec; 122(6):1181-5. PubMed ID: 11726894
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prostacyclin infusion during extracorporeal circulation foe coronary bypass.
    Rådegran K; Arén C; Teger-Nilsson AC
    J Thorac Cardiovasc Surg; 1982 Feb; 83(2):205-11. PubMed ID: 7035754
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The management of atrial fibrillation after cardiac surgery.
    Rho RW
    Heart; 2009 Mar; 95(5):422-9. PubMed ID: 19218267
    [No Abstract]   [Full Text] [Related]  

  • 29. Perioperative monitoring of primary and secondary hemostasis in coronary artery bypass grafting.
    Hertfelder HJ; Bös M; Weber D; Winkler K; Hanfland P; Preusse CJ
    Semin Thromb Hemost; 2005; 31(4):426-40. PubMed ID: 16149021
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Restenosis after coronary stent placement and randomization to a 4-week combined antiplatelet or anticoagulant therapy: six-month angiographic follow-up of the Intracoronary Stenting and Antithrombotic Regimen (ISAR) Trial.
    Kastrati A; Schühlen H; Hausleiter J; Walter H; Zitzmann-Roth E; Hadamitzky M; Elezi S; Ulm K; Dirschinger J; Neumann FJ; Schömig A
    Circulation; 1997 Jul; 96(2):462-7. PubMed ID: 9244213
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [New aspects of blood coagulation inhibitory therapy within the scope of percutaneous transluminal coronary angioplasty (PTCA)].
    Schächinger V; Zeiher AM
    Z Kardiol; 1995 Sep; 84(9):651-67. PubMed ID: 8525667
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Surgery of the foot and anticoagulant therapy].
    Denis A; Huber Levernieux C; Delpech G; Elmelik E
    Phlebologie; 1987; 40(2):341-6. PubMed ID: 3615610
    [No Abstract]   [Full Text] [Related]  

  • 33. Complications after placement of an intracoronary stent: nursing implications.
    Dabbs AD; Chambers CE; Macauley K
    Am J Crit Care; 1998 Mar; 7(2):117-22. PubMed ID: 9509225
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relationship of atrial fibrillation and stroke after coronary artery bypass graft surgery: when is anticoagulation indicated?
    Kollar A; Lick SD; Vasquez KN; Conti VR
    Ann Thorac Surg; 2006 Aug; 82(2):515-23. PubMed ID: 16863754
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combined antiplatelet and anticoagulant therapy: clinical benefits and risks.
    Eikelboom JW; Hirsh J
    J Thromb Haemost; 2007 Jul; 5 Suppl 1():255-63. PubMed ID: 17635734
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Blue toe syndrome after coronary artery bypass grafting].
    Fukushima Y; Yoshioka M; Niina K; Onitsuka T
    Kyobu Geka; 2001 Jun; 54(6):489-92. PubMed ID: 11424500
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antiplatelet therapy preceding coronary artery surgery: implications for bleeding, transfusion requirements and outcome.
    Picker SM; Kaleta T; Hekmat K; Kampe S; Gathof BS
    Eur J Anaesthesiol; 2007 Apr; 24(4):332-9. PubMed ID: 17241500
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Low-dose postoperative aprotinin reduces mediastinal drainage and blood product use in patients undergoing primary coronary artery bypass grafting who are taking aspirin: a prospective, randomized, double-blind, placebo-controlled trial.
    Alvarez JM; Jackson LR; Chatwin C; Smolich JJ
    J Thorac Cardiovasc Surg; 2001 Sep; 122(3):457-63. PubMed ID: 11547294
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prostacyclin reduces incidence of myocardial damage after coronary endarterectomy.
    Jonjev ZS; Nićin S; Mujović V; Petrović L; Radovanović N
    Ann Thorac Surg; 2004 Oct; 78(4):1299-303. PubMed ID: 15464489
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Postoperative pericardial effusion in patients receiving anticoagulants for deep vein thrombosis after coronary artery bypass graft surgery.
    Ambrosetti M; Ageno W; Salerno M; Pedretti RF
    J Thromb Haemost; 2005 Oct; 3(10):2367-8. PubMed ID: 16194218
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.